Table 2.
Effect of tranexamic acid on maternal death
| Tranexamic acid group (n=10 036) | Placebo group (n=9985) | RR (95% CI) | p value (two-sided) | |
|---|---|---|---|---|
| Bleeding | 155 (1·5%) | 191 (1·9 %) | 0·81 (0·65–1·00) | 0·045 |
| Pulmonary embolism | 10 (0·1%) | 11 (0·1) | 0·90 (0·38–2·13) | 0·82 |
| Organ failure | 25 (0·3%) | 18 (0·2%) | 1·38 (0·75–2·53) | 0·29 |
| Sepsis | 15 (0·2%) | 8 (0·1%) | 1·87 (0·79–4·40) | 0·15 |
| Eclampsia | 2 (0·02%) | 8 (0·1%) | 0·25 (0·05–1·17) | 0·057 |
| Other | 20 (0·2%) | 20 (0·2%) | 0·99 (0·54–1·85) | 0·99 |
| Any cause of death | 227 (2·3%) | 256 (2·6%) | 0·88 (0·74–1·05) | 0·16 |
Data are n (%), unless otherwise indicated. RR=risk ratio.